Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
These symptoms are typically mild and subside as your body adjusts to the medication
As more people begin taking GLP-1 receptor agonists and other incretin-based drugs for glycemic control and weight management, new side effects of these treatments (both good and bad) are emerging
They are incredibly effective at lowering A1C, often dropping it by 1% to 2%
The right choice depends on medical history, weight goals, lifestyle, insurance, and tolerance to side effects
G., Mebius, R
and, via DPP-IV inhibition or direct GLP-1 stimulation, engaging incretin-mediated neuroprotective signaling
US$ 22.78
US$ 25.74
US$ 22.21
US$ 22.10
US$ 28.29
